Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
S. Swathi Krishna, M. S. Sudheesh & Vidya Viswanad. (2023) Liposomal drug delivery to the lungs: a post covid-19 scenario. Journal of Liposome Research 33:4, pages 410-424.
Read now
Read now
Ashlee D. Brunaugh, Shivam Sharma & Hugh Smyth. (2021) Inhaled fixed-dose combination powders for the treatment of respiratory infections. Expert Opinion on Drug Delivery 18:8, pages 1101-1115.
Read now
Read now
Maria Malamatari, Satyanarayana Somavarapu, Kevin M.G. Taylor & Graham Buckton. (2016) Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders. Expert Opinion on Drug Delivery 13:3, pages 435-450.
Read now
Read now
Jerry Nesamony, Ishan S. Shah, Ashish Kalra & Rose Jung. (2014) Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation. Drug Development and Industrial Pharmacy 40:9, pages 1253-1263.
Read now
Read now
Cheng-Dong Hou, Jie-Xin Wang, Yuan Le, Hai-Kui Zou & Hong Zhao. (2012) Preparation of azithromycin nanosuspensions by reactive precipitation method. Drug Development and Industrial Pharmacy 38:7, pages 848-854.
Read now
Read now
Biswadip Sinha & Biswajit Mukherjee. (2012) Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model. Drug Development and Industrial Pharmacy 38:2, pages 171-179.
Read now
Read now
Burcu Devrim, Asuman Bozkır & Kandemir Canefe. (2011) Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations. Drug Development and Industrial Pharmacy 37:11, pages 1376-1386.
Read now
Read now
Articles from other publishers (42)
Katayoon Mireskandari, Yalda H. Ardakani, Ebrahim S. Moghadam, Farzaneh Ketabchi & Mohammadreza Rouini. (2023) Fundamentals and Applications of Isolated Perfused Lung (IPL) Model in
the Development of Pulmonary Drug Delivery. Current Drug Delivery 20:10, pages 1425-1440.
Crossref
Crossref
Ali Nokhodchi, Salonee Chavan & Taravat Ghafourian. (2023) In Vitro Dissolution and Permeability Testing of Inhalation Products: Challenges and Advances. Pharmaceutics 15:3, pages 983.
Crossref
Crossref
Petra Party, Márk László Klement, Piroska Szabó-Révész & Rita Ambrus. (2023) Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery. Pharmaceutics 15:2, pages 545.
Crossref
Crossref
Manisha Patel, Rupa Mazumder, Rakhi Mishra & Kamal Kant Kaushik. (2022) Potential of Nanotechnology-based Formulations in Combating Pulmonary
Infectious Diseases: A Current Scenario. Current Pharmaceutical Design 28:42, pages 3413-3427.
Crossref
Crossref
Umesh Banakar. 2022. Pharmaceutical Dissolution Testing, Bioavailability, and Bioequivalence. Pharmaceutical Dissolution Testing, Bioavailability, and Bioequivalence
294
319
.
Zachary Warnken, Hugh D. C. Smyth & Robert O. WilliamsIIIIII. 2022. Formulating Poorly Water Soluble Drugs. Formulating Poorly Water Soluble Drugs
1
31
.
Fabio Sonvico, Veronica Chierici, Giada Varacca, Eride Quarta, Davide D’Angelo, Ben Forbes & Francesca Buttini. (2021) RespiCellTM: An Innovative Dissolution Apparatus for Inhaled Products. Pharmaceutics 13:10, pages 1541.
Crossref
Crossref
Yi Guo, Hriday Bera, Changzhi Shi, Li Zhang, Dongmei Cun & Mingshi Yang. (2021) Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines. Acta Pharmaceutica Sinica B 11:8, pages 2565-2584.
Crossref
Crossref
Milo Gatti & Fabrizio De Ponti. (2021) Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities. Pharmaceutics 13:3, pages 302.
Crossref
Crossref
Chang Ren, Dexuan Kong, Chen Ning, Han Xing, Yujie Cheng, Yongjie Zhang, Yang Lu, Ning Li, Xijing Chen & Di Zhao. (2021) Improved Pharmacokinetic Characteristics of Ursolic Acid in Rats Following Intratracheal Instillation and Nose-Only Inhalation Exposure. Journal of Pharmaceutical Sciences 110:2, pages 905-913.
Crossref
Crossref
Maria Malamatari, Anastasia Charisi, Stavros Malamataris, Kyriakos Kachrimanis & Ioannis Nikolakakis. (2020) Spray Drying for the Preparation of Nanoparticle-Based Drug Formulations as Dry Powders for Inhalation. Processes 8:7, pages 788.
Crossref
Crossref
Kohei Togami. (2020) Intrapulmonary Pharmacokinetics and Drug Distribution Characteristics for the Treatment of Respiratory Diseases呼吸器疾患治療のための薬物の肺内動態及び肺組織分布特性の解明. YAKUGAKU ZASSHI 140:3, pages 345-354.
Crossref
Crossref
Basanth Babu Eedara, Ian G. Tucker, Zoran D. Zujovic, Thomas Rades, Jason R. Price & Shyamal C. Das. (2019) Crystalline adduct of moxifloxacin with trans-cinnamic acid to reduce the aqueous solubility and dissolution rate for improved residence time in the lungs. European Journal of Pharmaceutical Sciences 136, pages 104961.
Crossref
Crossref
Sarah Zellnitz, Eva Roblegg, Joana Pinto & Eleonore Fröhlich. (2019) Delivery of Dry Powders to the Lungs: Influence of Particle Attributes from a Biological and Technological Point of View. Current Drug Delivery 16:3, pages 180-194.
Crossref
Crossref
Snezana Radivojev, Sarah Zellnitz, Amrit Paudel & Eleonore Fröhlich. (2019) Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs. International Journal of Pharmaceutics 556, pages 45-56.
Crossref
Crossref
Ayca Yildiz-PeközOzlem AkbalS. Hande TekarslanA. Olcay SagirliLütfiye MulazimogluDeniz MorinaErdal Cevher. (2018) Preparation and Characterization of Doripenem-Loaded Microparticles for Pulmonary Delivery. Journal of Aerosol Medicine and Pulmonary Drug Delivery 31:6, pages 347-357.
Crossref
Crossref
Diogo Silva Pellosi, Ivana d'Angelo, Sara Maiolino, Emma Mitidieri, Roberta d'Emmanuele di Villa Bianca, Raffaella Sorrentino, Fabiana Quaglia & Francesca Ungaro. (2018) In vitro/in vivo investigation on the potential of Pluronic® mixed micelles for pulmonary drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 130, pages 30-38.
Crossref
Crossref
Richard S. Roberts, Sara Sevilla, Manel Ferrer, Joan Taltavull, Begoña Hernández, Victor Segarra, Jordi Gràcia, Martin D. Lehner, Amadeu Gavaldà, Miriam Andrés, Judit Cabedo, Dolors Vilella, Peter Eichhorn, Elena Calama, Carla Carcasona & Montserrat Miralpeix. (2018)
4-Amino-7,8-dihydro-1,6-naphthyridin-5(6
H
)-ones as Inhaled Phosphodiesterase Type 4 (PDE4) Inhibitors: Structural Biology and Structure–Activity Relationships
. Journal of Medicinal Chemistry 61:6, pages 2472-2489.
Crossref
Crossref
Duy-Khiet Ho, Ana Costa, Chiara De Rossi, Cristiane de Souza Carvalho-Wodarz, Brigitta Loretz & Claus-Michael Lehr. (2018) Polysaccharide Submicrocarrier for Improved Pulmonary Delivery of Poorly Soluble Anti-infective Ciprofloxacin: Preparation, Characterization, and Influence of Size on Cellular Uptake. Molecular Pharmaceutics 15:3, pages 1081-1096.
Crossref
Crossref
Maria Malamatari, Kevin M.G. Taylor, Stavros Malamataris, Dennis Douroumis & Kyriakos Kachrimanis. (2018) Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discovery Today 23:3, pages 534-547.
Crossref
Crossref
Alessandro FioniEwa SelgValentina CenacchiFernando AcevedoGiandomenico BroginPer GerdePaola Puccini. (2018) Investigation of Lung Pharmacokinetic of the Novel PDE4 Inhibitor CHF6001 in Preclinical Models: Evaluation of the PreciseInhale Technology. Journal of Aerosol Medicine and Pulmonary Drug Delivery 31:1, pages 61-70.
Crossref
Crossref
Sitaram P. Velaga, Jelena Djuris, Sandra Cvijic, Stavroula Rozou, Paola Russo, Gaia Colombo & Alessandra Rossi. (2018) Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products. European Journal of Pharmaceutical Sciences 113, pages 18-28.
Crossref
Crossref
Joshua P. Thompson & Dennis F. Thompson. (2016) Nebulized Fentanyl in Acute Pain. Annals of Pharmacotherapy 50:10, pages 882-891.
Crossref
Crossref
Aateka Patel, A. Woods, Yanira Riffo-Vasquez, Anna Babin-Morgan, Marie-Christine Jones, Stuart Jones, Kavitha Sunassee, Stephen Clark, Rafael T. M. de Rosales, Clive Page, Domenico Spina, Ben Forbes & Lea Ann Dailey. (2016) Lung inflammation does not affect the clearance kinetics of lipid nanocapsules following pulmonary administration. Journal of Controlled Release 235, pages 24-33.
Crossref
Crossref
Zhi-Bing Zhang, Miao-Ling Xie, Yun-Yun Kuang, Jie-Xin Wang, Yuan Le, Xiao-Fei Zeng & Jian-Feng Chen. (2016) Preparation of amorphous drug nanoparticles by high-gravity reactive precipitation technique. Chemical Engineering and Processing: Process Intensification 104, pages 253-261.
Crossref
Crossref
Zachary Warnken, Hugh D. C. Smyth & Robert O. WilliamsIIIIII. 2016. Formulating Poorly Water Soluble Drugs. Formulating Poorly Water Soluble Drugs
1
39
.
Maria Malamatari, Satyanarayana Somavarapu, Mark Bloxham & Graham Buckton. (2015) Nanoparticle agglomerates of indomethacin: The role of poloxamers and matrix former on their dissolution and aerosolisation efficiency. International Journal of Pharmaceutics 495:1, pages 516-526.
Crossref
Crossref
Yun-Yun Kuang, Zhi-Bing Zhang, Miao-Ling Xie, Jie-Xin Wang, Yuan Le & Jian-Feng Chen. (2015) Large-Scale Preparation of Amorphous Cefixime Nanoparticles by Antisolvent Precipitation in a High-Gravity Rotating Packed Bed. Industrial & Engineering Chemistry Research 54:33, pages 8157-8165.
Crossref
Crossref
Nathalie Wauthoz & Karim Amighi. 2015. Pulmonary Drug Delivery. Pulmonary Drug Delivery
87
122
.
Jens Markus Borghardt, Benjamin Weber, Alexander Staab & Charlotte Kloft. (2015) Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs. The AAPS Journal 17:4, pages 853-870.
Crossref
Crossref
Romain Merlos, Karim Amighi & Nathalie Wauthoz. (2014) Recent Developments in Inhaled Triazoles Against Invasive Pulmonary Aspergillosis. Current Fungal Infection Reports 8:4, pages 331-342.
Crossref
Crossref
A. Sofia Silva, Márcia T. Tavares & Ana Aguiar-Ricardo. (2014) Sustainable strategies for nano-in-micro particle engineering for pulmonary delivery. Journal of Nanoparticle Research 16:11.
Crossref
Crossref
Simone R. Carvalho, Alan B. Watts, Jay I. Peters, Sha Liu, Soraya Hengsawas, Manuel S. Escotet-Espinoza & Robert O. Williams III. (2014) Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats. European Journal of Pharmaceutics and Biopharmaceutics 88:1, pages 136-147.
Crossref
Crossref
Ali Shayanfar & Abolghasem Jouyban. (2014) Physicochemical characterization of a new cocrystal of ketoconazole. Powder Technology 262, pages 242-248.
Crossref
Crossref
Cristina Loira-Pastoriza, Julie Todoroff & Rita Vanbever. (2014) Delivery strategies for sustained drug release in the lungs. Advanced Drug Delivery Reviews 75, pages 81-91.
Crossref
Crossref
Francesca Buttini, Michele Miozzi, Anna Giulia Balducci, Paul G. Royall, Gaetano Brambilla, Paolo Colombo, Ruggero Bettini & Ben Forbes. (2014) Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers. International Journal of Pharmaceutics 465:1-2, pages 42-51.
Crossref
Crossref
Yi-Bo Wang, Alan B. Watts, Jay I. Peters & Robert O. WilliamsIIIIII. (2014) The impact of pulmonary diseases on the fate of inhaled medicines—A review. International Journal of Pharmaceutics 461:1-2, pages 112-128.
Crossref
Crossref
Christophe Duret, Romain Merlos, Nathalie Wauthoz, Thami Sebti, Francis Vanderbist & Karim Amighi. (2014) Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention. European Journal of Pharmaceutics and Biopharmaceutics 86:1, pages 46-54.
Crossref
Crossref
Christian A Ruge, Julian Kirch & Claus-Michael Lehr. (2013) Pulmonary drug delivery: from generating aerosols to overcoming biological barriers—therapeutic possibilities and technological challenges. The Lancet Respiratory Medicine 1:5, pages 402-413.
Crossref
Crossref
Hélène L. Dugas, Jay I. Peters & Robert O. WilliamsIIIIII. (2013) Nebulization of mycophenolate mofetil inhalation suspension in rats: Comparison with oral and pulmonary administration of Cellcept®. International Journal of Pharmaceutics 441:1-2, pages 19-29.
Crossref
Crossref
Stephanie Bosselmann & Robert O. WilliamsIIIIII. 2012. Formulating Poorly Water Soluble Drugs. Formulating Poorly Water Soluble Drugs
1
26
.
Bo Olsson, Eva Bondesson, Lars Borgström, Staffan Edsbäcker, Stefan Eirefelt, Katarina Ekelund, Lena Gustavsson & Tove Hegelund-Myrbäck. 2011. Controlled Pulmonary Drug Delivery. Controlled Pulmonary Drug Delivery
21
50
.